[ad_1]
The US Food and Drug Administration (FDA) has approved a new drug for the treatment of cancer in adults and children, based on genetic mutations rather than the type of disease.
The drug called Vitrakvi and its scientific name LAROTECTINIB have been approved for the treatment of cancers that occur anywhere in the body.
NITCAVI is the first drug designed from the start to fight the genetic mutation of the disease, regardless of the type of cancer, said NBC.
The FDA's approval is an important step in the treatment of cancer, "FDA Commissioner Scott Gottlieb said in a statement," The base of the tumor genes, regardless of their origin in the body. "
"It will help patients get" fast treatment, "he said.
He added that the drug treats people with different tumors, but that it has a common genetic mutation, noting that this mutation was not available a decade ago because knowledge about genetic mutations were then fewer than now.
Source link
